Ligand validation:3KLS

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3KLS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3KLS_NAG_B_1681	7%	50%	0.359	0.812	0.74	1.17	-	1	0	0	100%	0.9333
3KLS_NAG_A_1682	0%	54%	0.579	0.646	0.68	1.09	-	-	0	0	100%	0.9333
3CU7_NAG_A_2003	20%	59%	0.246	0.848	0.58	0.98	-	1	0	0	100%	0.9333
3PVM_NAG_B_2001	11%	27%	0.258	0.777	0.81	2.07	1	3	1	0	100%	0.9333
3PRX_NAG_A_2003	9%	5%	0.287	0.779	1.89	3.34	5	13	1	0	100%	0.9333
3KM9_NAG_B_1679	2%	53%	0.35	0.586	0.7	1.1	-	1	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.